Statistics for Karyopharm Therapeutics (id:8011 KPTI)
Valuation metrics
Market cap
97.12M
Enterprise value
231.10M
Trailing P/E (ttm)
-0.68
Forward P/E
-1.09
PEG ratio
-1.09
Price/Sales (ttm)
0.65
Price/Book (mrq)
-0.66
Enterprise Value/Revenue
1.56
Enterprise Value/EBITDA
-1.84
Overview
Shares outstanding
125.32M
Float
113.91M
Shares short
17.69M
% Held by insiders
0.06%
% Held by institutions
0.50%
Average volume (10 days)
684.69K
Average volume (90 days)
Price summary
52-Week low
0.62
52-Week high
1.95
52-Week change
16.21%
Beta
0.15
50-Day moving average
0.82
200-Day moving average
1.02
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
-58.93%
Operating margin
-67.77%
Operational effectiveness
Return on assets
-34.27%
Return on equity
105.06%
Income statement
Revenue (ttm)
1.25
Revenue per share (ttm)
1.25
Quarterly revenue growth (yoy)
Gross profit (ttm)
141.09M
EBITDA
-125,634,000.00
Net income to common (ttm)
-87,479,000.00
Diluted EPS (ttm)
-1.05
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
133.53M
Total cash per share (mrq)
1.07
Total debt (mrq)
267.76M
Total Debt/Equity (mrq)
-1.68
Current ratio (mrq)
300.40%
Book value per share (mrq)
-1.27
Cash flow
Cash flow statement
-120,261,000.00
Levered free cash flow (LFCF)
-72,264,496.00